Dexcom G6 is now available
for Medicare patients.*

Get your patients started quickly and conveniently through retail pharmacy.

*See eligibility criteria here.

Prescribe today


Dexcom G6 is the first real-time integrated continuous glucose monitor (iCGM). Zero fingersticks or scanning required.

If your glucose alerts and readings from tht G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.


Dexcom CGM is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.1,2



A suite of alerts and a fixed Urgent Low alarm can help warn patients of high or low glucose levels.

The CGM that your Medicare patients have been waiting for.

The Dexcom G6 Continuous Glucose Monitoring (CGM) System offers a 10-day wear sensor, an easy-to-use applicator,3 and remote monitoring — giving your Medicare patients more freedom and flexibility to manage their diabetes.

Medicare coverage and prescribing information

The Dexcom G6 CGM System

Research & Resources

Person using the Dexcom app on a tablet.

Medicare CGM

Learn more about CGM features and benefits for your type 1 and type 2 Medicare patients.

A group of business people gathered around a tablet.

Proven Outcomes

Studies show that Dexcom CGM use can support significant reductions in A1C in seniors. 1-2, 4

A group of business people gathered around a tablet.

Frequently Asked Questions

Learn about Medicare coverage criteria, distribution options, and more.

Prescribe today

† Separate Follow app required. Internet connectivity required for data sharing. Followers should always confirm readings on the Dexcom G6 app or Receiver before making treatment decisions.
1 Beck RW, et al. JAMA. 2017; 317(4); 371-378.
2 Welsh JB, et al. Diabetes Technology Ther. 2019;21(3):128-132.
3 Dexcom G6 CGM System User Guide, 2018.
4 Pratley RE. Wireless Innovations for Seniors with Diabetes Mellitus—Primary Results of the WISDM Study. Oral presentation: American Diabetes Association 79th Scientific Sessions; June 7-11, San Francisco, CA.